Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Current Allergy and Asthma Reports
Published in: Current Allergy and Asthma Reports 7/2019

01-07-2019 | Allergic Rhinitis | Otitis (DP Skoner, Section Editor)

Vitamin D and Otitis Media

Authors: Rebecca E. Walker, Jim Bartley, Carlos A. Camargo Jr, Edwin A. Mitchell

Published in: Current Allergy and Asthma Reports | Issue 7/2019

Login to get access

Abstract

Purpose of Review

To examine the relationship between vitamin D and otitis media.

Recent Findings

Vitamin D deficiency has been associated with several respiratory diseases, including otitis media. Vitamin D supplementation may reduce the risk of otitis media. This relationship may be explained by vitamin D supporting the immune system by upregulating antimicrobial peptides which are effective against otopathogens and biofilm formation, supporting a less inflammatory immune response, or promoting beneficial commensal bacteria.

Summary

This review will explore risk factors of both otitis media and vitamin D deficiency, the evidence of vitamin D being beneficial for various forms of otitis media, and possible mechanisms of action.
Literature
1.
Gates GA, Klein JO, Lim DJ, Mogi G, Ogra PL, Pararella MM, et al. Recent advances in otitis media. 1. Definitions, terminology, and classification of otitis media. Ann Otol Rhinol Laryngol Suppl. 2002;188:8.PubMed
2.
American Academy of Pediatrics and American Academy of Family Physicians. Diagnosis and management of acute otitis media. Pediatrics. 2004;113(5):1451–65.CrossRef
3.
Verhoeff M, van der Veen EL, Rovers MM, Sanders EAM, Schilder AGM. Chronic suppurative otitis media: a review. Int J Pediatr Otorhinolaryngol. 2006;70(1):1–12.PubMedCrossRef
4.
Monasta L, Ronfani L, Marchetti F, Montico M, Brumatti LV, Bavcar A, et al. Burden of disease caused by otitis media: systematic review and global estimates. PLoS One. 2012;7(4):e36226.PubMedPubMedCentralCrossRef
5.
Dewey C, Midgeley E, Maw R. The relationship between otitis media with effusion and contact with other children in a British cohort studied from 8 months to 3 1/2 years. Int J Pediatr Otorhinolaryngol. 2000;55(1):33–45.PubMedCrossRef
6.
Chalmers D, Stewart I, Silva P, Mulvena A. Otitis media with effusion in children: the Dunedin study. London: Mac Keith Press; 1989.
7.
Casselbrant ML, Brostoff LM, Cantekin EI, Flaherty MR, Doyle WJ, Bluestone CD, et al. Otitis media with effusion in preschool children. Laryngoscope. 1985;95(4):428–36.PubMedCrossRef
8.
Marchisio P, Principi N, Passali D, Salpietro DC, Boschi G, Chetri G, et al. Epidemiology and treatment of otitis media with effusion in children in the first year of primary school. Acta Otolaryngol. 1998;118(4):557–62.PubMedCrossRef
9.
10.
Bhutta MF. Epidemiology and pathogenesis of otitis media: construction of a phenotype landscape. Audiol Neurootol. 2014;19(3):210–23.PubMedCrossRef
11.
12.
Gultekin E, Develioğlu ÖN, Yener M, Ozdemir I, Külekçi M. Prevalence and risk factors for persistent otitis media with effusion in primary school children in Istanbul, Turkey. Auris Nasus Larynx. 2010;37(2):145–9.PubMedCrossRef
13.
Schappert SM. Office visits for otitis media: United States, 1975-90. Adv Data. 1992;214:1–19.
14.
Finkelstein JA, Metlay JP, Davis RL, Rifas-Shiman SL, Dowell SF, Platt R. Antimicrobial use in defined populations of infants and young children. Arch Pediatr Adolesc Med. 2000;154(4):395–400.PubMedCrossRef
15.
Gunasekera H, Knox S, Morris P, Britt H, McIntyre P, Craig JC. The spectrum and management of otitis media in Australian indigenous and nonindigenous children: a national study. Pediatr Infect Dis J. 2007;26(8):689–92.PubMedCrossRef
16.
Australian Institute of Health and Welfare. Australian hospital statistics 2009–10. Canberra: Australian Institute of Health and Welfare; 2011. p. 138.
17.
18.
Rosenfeld RM, Shin JJ, Schwartz SR, Coggins R, Gagnon L, Hackell JM, et al. Clinical practice guideline otitis media with effusion (update). Otolaryngol Head Neck Surg. 2016;154(1 suppl):S1–S41.PubMedCrossRef
19.
Akcan FA, Dündar Y, Akcan HB, Uluat A, Cebeci D, Ünlü İ. Evaluation of nasal mucociliary clearance time in patients with vitamin-D deficiency. Eur Arch Otorhinolaryngol 2019;276:1075-80.PubMedCrossRef
20.
Liu PT, Stenger S, Tang DH, Modlin RL. Cutting edge: vitamin D-mediated human antimicrobial activity against mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol. 2007;179(4):2060–3.PubMedCrossRef
21.
Ooi JH, Li Y, Rogers CJ, Cantorna MT. Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate–induced colitis. J Nutr. 2013;143(10):1679–86.PubMedPubMedCentralCrossRef
22.
Camargo CA, Ganmaa D, Frazier AL, Kirchberg FF, Stuart JJ, Kleinman K, et al. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics. 2012;130(3):e561–e7.PubMedCrossRef
23.
Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583.PubMedPubMedCentralCrossRef
24.
Martineau A, Takeda A, Nurmatov U, Sheikh A, Griffiths CJ. Vitamin D for the management of asthma. Cochrane Database Syst Rev. 2016;9:CD011511.PubMed
25.
Walker RE, Bartley J, Camargo CA, Flint D, Thompson J, Mitchell EA. Higher serum 25 (OH) D concentration is associated with lower risk of chronic otitis media with effusion: a case control study. Acta Paediatr. 2017;106:1487–92.PubMedCrossRef
26.
Marom T, Marchisio P, Tamir SO, Torretta S, Gavriel H, Esposito S. Complementary and alternative medicine treatment options for otitis media: a systematic review. Medicine. 2016;95(6):e2695.PubMedPubMedCentralCrossRef
27.
28.
Looker AC, Cl J, Lacher DA, Pfeiffer CM, Schleicher RL, Sempos CT. Vitamin D status: United States, 2001–2006. NCHS Data Brief. 2011;59(1941–4927 (Electronic)):1–8.
29.
Val S, Poley M, Anna K, Nino G, Brown K, Pérez-Losada M, et al. Characterization of mucoid and serous middle ear effusions from patients with chronic otitis media: implication of different biological mechanisms? Pediatr Res. 2018;84(2):296–305.PubMedPubMedCentralCrossRef
30.
Tos M, Bak-Pedersen K. Goblet cell population in the pathological middle ear and eustachian tube of children and adults. Ann Otol Rhinol Laryngol. 1977;86(2):209–18.PubMedCrossRef
31.
Cayé-Thomasen P, Tos M. Histopathologic differences due to bacterial species in acute otitis media. Int J Pediatr Otorhinolaryngol. 2002;63(2):99–110.PubMedCrossRef
32.
Walker RE, Walker CG, Camargo CA Jr, Bartley J, Flint D, Thompson JMD, et al. Nasal microbial composition and chronic otitis media with effusion: a case-control study. PLoS One. 2019;14(2):e0212473.PubMedPubMedCentralCrossRef
33.
Ngo CC, Massa HM, Thornton RB, Cripps AW. Predominant bacteria detected from the middle ear fluid of children experiencing otitis media: a systematic review. PLoS One. 2016;11(3):e0150949.PubMedPubMedCentralCrossRef
34.
Yeo SG, Park DC, Hong SM, Cha CI, Kim MG. Bacteriology of chronic suppurative otitis media–a multicenter study. Acta Otolaryngol. 2007;127(10):1062–7.PubMedCrossRef
35.
Lee H-Y, Andalibi A, Webster P, Moon S-K, Teufert K, Kang S-H, et al. Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae. BMC Infect Dis. 2004;4(1):12.PubMedPubMedCentralCrossRef
36.
Val S, Poley M, Brown K, Choi R, Jeong S, Colberg-Poley A, et al. Proteomic characterization of middle ear fluid confirms neutrophil extracellular traps as a predominant innate immune response in chronic otitis media. PLoS One. 2016;11(4):e0152865.PubMedPubMedCentralCrossRef
37.
38.
S-q Z, Li J, Liu H, Zhang Q-g, Wang Y, D-m H. Role of interleukin-10 and transforming growth factor beta 1 in otitis media with effusion. Chin Med J. 2009;122(18):2149–54.
39.
40.
Lin J, Haruta A, Kawano H, Ho SB, Adams GL, Juhn SK, et al. Induction of mucin gene expression in middle ear of rats by tumor necrosis factor—α: potential cause for mucoid otitis media. J Infect Dis. 2000;182(3):882–7.PubMedCrossRef
41.
Smirnova MG, Birchall JP, Pearson JP. In vitro study of IL-8 and goblet cells: possible role of IL-8 in the aetiology of otitis media with effusion. Acta Otolaryngol. 2002;122(2):146–52.PubMedCrossRef
42.
Sobol SE, Taha R, Schloss MD, Mazer BD, Manoukian JJ, Tewfik TL, et al. Th2 cytokine expression in atopic children with otitis media with effusion. J Allergy Clin Immunol. 2002;109(Supplement 1):S63–S.CrossRef
43.
Jang C-H, Kim Y-H. Characterization of cytokines present in pediatric otitis media with effusion: comparison of allergy positive and negative. Int J Pediatr Otorhinolaryngol. 2002;66(1):37–40.PubMedCrossRef
44.
Thornton RB, Wiertsema SP, Kirkham L-AS, Rigby PJ, Vijayasekaran S, Coates HL, et al. Neutrophil extracellular traps and bacterial biofilms in middle ear effusion of children with recurrent acute otitis media–a potential rreatment target. PLoS One. 2013;8(2):e53837.PubMedPubMedCentralCrossRef
45.
Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA. 2006;296(2):202–11.PubMedPubMedCentralCrossRef
46.
47.
Aryan Z, Rezaei N, Camargo CA Jr. Vitamin D status, aeroallergen sensitization, and allergic rhinitis: a systematic review and meta-analysis. Int Rev Immunol. 2017;36(1):41–53.PubMedCrossRef
48.
Walker RE, Bartley J, Flint D, Thompson JM, Mitchell EA. Determinants of chronic otitis media with effusion in preschool children: a case-control study. BMC Pediatr. 2017;17(1):4.PubMedPubMedCentralCrossRef
49.
Chun RF, Peercy BE, Adams JS, Hewison M. Vitamin D binding protein and monocyte response to 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D: analysis by mathematical modeling. PLoS One. 2012;7(1):e30773.PubMedPubMedCentralCrossRef
50.
51.
•• Marchisio P, Consonni D, Baggi E, Zampiero A, Bianchini S, Terranova L, et al. Vitamin D supplementation reduces the risk of acute otitis media in otitis-prone children. Pediatr Infect Dis J. 2013;32(10):1055–60 Only study of vitamin D supplementation for OM. PubMedCrossRef
52.
Love JF, Tran-Winkler HJ, Wessels MR. Vitamin D and the human antimicrobial peptide LL-37 enhance group a streptococcus resistance to killing by human cells. MBio. 2012;3(5):e00394–12.PubMedPubMedCentralCrossRef
53.
54.
• Cayir A, Turan MI, Ozkan O, Cayir Y. Vitamin D levels in children diagnosed with acute otitis media. J Pak Med Assoc. 2014;64(11):1274–7 Lower vitamin D associated with AOM. PubMed
55.
Cayir A, Turan MI, Ozkan O, Cayir Y, Kaya A, Davutoglu S et al. Serum vitamin D levels in children with recurrent otitis media. Eur Arch Otorhinolaryngol. 2014;271:689–93.PubMedCrossRef
56.
Linday LA, Shindledecker RD, Dolitsky JN, Chen TC, Holick MF. Plasma 25-hydroxyvitamin D levels in young children undergoing placement of tympanostomy tubes. Ann Otol Rhinol Laryngol. 2008;117(10):740–4.PubMedCrossRef
57.
Elemraid MA, Mackenzie IJ, Fraser WD, Harper G, Faragher B, Atef Z, et al. A case-control study of nutritional factors associated with chronic suppurative otitis media in yemeni children. Eur J Clin Nutr 2011;65(8):895-902.PubMedCrossRef
58.
Park M, Lee JS, Lee JH, Oh SH, Park MK. Prevalence and risk factors of chronic otitis media: the Korean national health and nutrition examination survey 2010–2012. PLoS One. 2015;10(5):e0125905.PubMedPubMedCentralCrossRef
59.
Hosseini S, Khajavi M, Eftekharian A, Akbari N. Vitamin D levels in children with otitis media with effusion: a case-control study. Thrita. 2016;5:e31977
60.
Li H-B, Tai X-H, Sang Y-H, Jia J-P, Xu Z-M, Cui X-F et al. Association between vitamin D and development of otitis media: a PRISMA-compliant meta-analysis and systematic review. Medicine (Baltimore) 2016;95:e4739.PubMedPubMedCentralCrossRef
61.
Thornton KA, Marín C, Mora-Plazas M, Villamor E. Vitamin D deficiency associated with increased incidence of gastrointestinal and ear infections in school-age children. Pediatr Infect Dis J. 2013;32:585–93.PubMedCrossRef
62.
63.
Cannell JJ, Vieth R, Willett W, Zasloff M, Hathcock JN, White JH, et al. Cod liver oil, vitamin a toxicity, frequent respiratory infections, and the vitamin D deficiency epidemic. Ann Otol Rhinol Laryngol. 2008;117(11):864–70.PubMedCrossRef
64.
Bhan I, Camargo CA, Wenger J, Ricciardi C, Ye J, Borregaard N, et al. Circulating levels of 25-hydroxyvitamin D and human cathelicidin in healthy adults. J Allergy Clin Immunol. 2011;127(5):1302–4.PubMedPubMedCentralCrossRef
65.
66.
McGillivary G, Ray WC, Bevins CL, Munson RS Jr, Bakaletz LO. A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media. Mol Immunol. 2007;44(9):2446–58.PubMedCrossRef
67.
Overhage J, Campisano A, Bains M, Torfs ECW, Rehm BHA, Hancock REW. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun. 2008;76(9):4176–82.PubMedPubMedCentralCrossRef
68.
Chennupati SK, Chiu AG, Tamashiro E, Banks CA, Cohen MB, Bleier BS, et al. Effects of an LL-37-derived antimicrobial peptide in an animal model of biofilm Pseudomonas sinusitis. Am J Rhinol Allergy. 2009;23(1):46–51.PubMedCrossRef
69.
Dean SN, Bishop BM, van Hoek ML. Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus. BMC Microbiol. 2011;11(1):1.CrossRef
70.
71.
Olsen K, Falch BM, Danielsen K, Johannessen M, Ericson Sollid JU, Thune I, et al. Staphylococcus aureus nasal carriage is associated with serum 25-hydroxyvitamin D levels, gender and smoking status. The Tromsø staph and skin study. Eur J Clin Microbiol Infect Dis. 2012;31(4):465–73.PubMedCrossRef
72.
Kanhere M, He J, Chassaing B, Ziegler TR, Alvarez JA, Ivie EA, et al. Bolus weekly vitamin D3 supplementation impacts gut and airway microbiota in adults with cystic fibrosis: a double-blind, randomized, placebo-controlled clinical trial. J Clin Endocrinol Metab. 2017;103(2):564–74.PubMedCentralCrossRef
73.
Jin D, Wu S, Zhang Y-g, Lu R, Xia Y, Dong H, et al. Lack of vitamin D receptor causes dysbiosis and changes the functions of the murine intestinal microbiome. Clin Ther. 2015;37(5):996–1009.PubMedCrossRef
74.
Wu S, Zhang Y-G, Lu R, Xia Y, Zhou D, Petrof EO, et al. Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis. Gut. 2015;64(7):1082–94.PubMedCrossRef
75.
Wang J, Thingholm LB, Skiecevičienė J, Rausch P, Kummen M, Hov JR, et al. Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota. Nat Genet. 2016;48(11):1396–406.PubMedPubMedCentralCrossRef
76.
Lappan R, Imbrogno K, Sikazwe C, Anderson D, Mok D, Coates H, et al. A microbiome case-control study of recurrent acute otitis media identified potentially protective bacterial genera. BMC Microbiol. 2018;18(1):13.PubMedPubMedCentralCrossRef
77.
78.
Wright ED, Hurst D, Miotto D, Giguere C, Hamid Q. Increased expression of major basic protein (MBP) and interleukin-5 (IL-5) in middle ear biopsy specimens from atopic patients with persistent otitis media with effusion. Otolaryngol Head Neck Surg. 2000;123(5):533–8.PubMedCrossRef
79.
Wren JT, Blevins LK, Pang B, King LB, Perez AC, Murrah KA, et al. Influenza a virus alters pneumococcal nasal colonization and middle ear infection independently of phase variation. Infect Immun. 2014;82(11):4802–12.PubMedPubMedCentralCrossRef
80.
Marks LR, Davidson BA, Knight PR, Hakansson AP. Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic colonization to disease. mBio. 2013;4(4):e00438–13.PubMedPubMedCentralCrossRef
81.
Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza a in schoolchildren. Am J Clin Nutr. 2010;91(5):1255–60.PubMedCrossRef
82.
Brockman-Schneider RA, Pickles RJ, Gern JE. Effects of vitamin D on airway epithelial cell morphology and rhinovirus replication. PLoS One. 2014;9(1):e86755.PubMedPubMedCentralCrossRef
83.
84.
Hansdottir S, Monick MM, Lovan N, Powers L, Gerke A, Hunninghake GW. Vitamin D decreases respiratory syncytial virus induction of NF-kB linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol. 2010;184(2):965–74.PubMedCrossRef
85.
Zhang Y, Leung DYM, Richers BN, Liu Y, Remigio LK, Riches DW, et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012;188(5):2127–35.PubMedPubMedCentralCrossRef
86.
Zhu Y, Mahon BD, Froicu M, Cantorna MT. Calcium and 1α, 25-dihydroxyvitamin D3 target the TNF-α pathway to suppress experimental inflammatory bowel disease. Eur J Immunol. 2005;35(1):217–24.PubMedCrossRef
87.
Coussens AK, Wilkinson RJ, Hanifa Y, Nikolayevskyy V, Elkington PT, Islam K, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci. 2012;109(38):15449–54.PubMedCrossRef
88.
Preciado D, Lin J, Wuertz B, Rose M. Cigarette smoke activates NFκB and induces Muc5b expression in mouse middle ear cells. Laryngoscope. 2008;118(3):464–71.PubMedPubMedCentralCrossRef
89.
Preciado D, Kuo E, Ashktorab S, Manes P, Rose M. Cigarette smoke activates NFκB-mediated Tnf-α release from mouse middle ear cells. Laryngoscope. 2010;120(12):2508–15.PubMedPubMedCentralCrossRef
90.
Kim H-B, Lim SH, Cho CG, Choi HS. Influence of vitamin D deficiency on progression of experimental otitis media in rats. Endocrinol Metab. 2018;33(2):296–304.CrossRef
91.
Lai G, Wu C, Hong J, Song Y. 1, 25-Dihydroxyvitamin D3 (1, 25-(OH) 2D3) attenuates airway remodeling in a murine model of chronic asthma. J Asthma. 2013;50(2):133–40.PubMedCrossRef
92.
Reid D, Toole BJ, Knox S, Talwar D, Harten J, O’Reilly DSJ, et al. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr. 2011;93(5):1006–11.PubMedCrossRef
Metadata
Title
Vitamin D and Otitis Media
Authors
Rebecca E. Walker
Jim Bartley
Carlos A. Camargo Jr
Edwin A. Mitchell
Publication date
01-07-2019
Publisher
Springer US
Published in
Current Allergy and Asthma Reports / Issue 7/2019
Print ISSN: 1529-7322
Electronic ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-019-0866-2